<DOC>
	<DOCNO>NCT02556788</DOCNO>
	<brief_summary>Assessment efficacy safety CD5789 50µg/g cream apply daily 12 week subject acne vulgaris .</brief_summary>
	<brief_title>Double-Blind Efficacy Safety CD5789 50µg/g Cream Versus Vehicle Cream Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>The subject male female , 9 year age old , Screening visit . The Subject moderate acne Screening Baseline . The subject female non childbearing potential The subject female childbearing potential negative pregnancy test strictly abstinent agrees use effective approve contraceptive method duration study least 1 month last study drug application . The subject severe form acne ( e.g. , acne conglobate , acne fulminant ) secondary acne form ( e.g. , chloracne , druginduced acne , etc. ) . The subject uncontrolled serious disease medical surgical condition may either interfere interpretation trial result and/or put subject significant risk ( accord Investigator 's judgment ) subject take part trial . The subject expose excessive ultraviolet ( UV ) radiation within one month prior Baseline visit subject planning intense UV exposure study ( i.e. , occupational exposure sun , sunbathing , tan salon use , phototherapy , etc . ) The subject unwilling refrain use prohibit medication clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Acne vulgaris</keyword>
</DOC>